2007
DOI: 10.1016/j.pnpbp.2006.10.001
|View full text |Cite
|
Sign up to set email alerts
|

An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
121
0
4

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 161 publications
(131 citation statements)
references
References 21 publications
6
121
0
4
Order By: Relevance
“…The present data reveal that system x c Ϫ represents a novel target capable of preventing plasticity that underlies behaviors used to model aspects of addiction and are consistent with clinical studies indicating efficacy for N-acetylcysteine as an anticraving agent for cocaine addiction (Larowe et al, 2006;Mardikian et al, 2007). Aside from system x c Ϫ, numerous mechanisms may be capable of releasing glutamate into the extrasynaptic compartment including vesicular release from astrocytes (Bezzi et al, 2004;Zhang et al, 2004), nonvesicular release from astrocytic gap junction hemichannels (Ye et al, 2003), volume-sensitive organic anion channels (Strange et al, 1996;Basarsky et al, 1999), or hydrolysis of N-acetylaspartylglutamate (Blakely et al, 1988;Zhou et al, 2005).…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…The present data reveal that system x c Ϫ represents a novel target capable of preventing plasticity that underlies behaviors used to model aspects of addiction and are consistent with clinical studies indicating efficacy for N-acetylcysteine as an anticraving agent for cocaine addiction (Larowe et al, 2006;Mardikian et al, 2007). Aside from system x c Ϫ, numerous mechanisms may be capable of releasing glutamate into the extrasynaptic compartment including vesicular release from astrocytes (Bezzi et al, 2004;Zhang et al, 2004), nonvesicular release from astrocytic gap junction hemichannels (Ye et al, 2003), volume-sensitive organic anion channels (Strange et al, 1996;Basarsky et al, 1999), or hydrolysis of N-acetylaspartylglutamate (Blakely et al, 1988;Zhou et al, 2005).…”
Section: Discussionsupporting
confidence: 84%
“…It may seem paradoxical that targeting cystine-glutamate exchange, which increases nonvesicular glutamate, is effective in reducing cocaine-induced behaviors in rodents or drug craving and use in humans because these behaviors require increased glutamate signaling (Cornish and Kalivas, 2000;Baker et al, 2003;Di Ciano and Everitt, 2003;McFarland et al, 2003;Larowe et al, 2006;Mardikian et al, 2007). However, this may reflect the existence of multiple, functionally distinct pools of glutamate.…”
Section: Discussionmentioning
confidence: 99%
“…Other regimens, including ShA regimens that do not lead to CP-AMPAR accumulation, provide insight into strategies for decreasing addictive behavior under different conditions. The most striking example concerns the drug N-acetylcysteine, which reduces cocaine-related behaviors after non-contingent cocaine exposure and ShA cocaine self-administration and has shown promise in clinical trials (Mardikian et al, 2007;Amen et al, 2011;Olive et al, 2012).…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…It also represents an advance in "bench to bedside" translation, since daily administration of medication during extinction more closely models the treatment approaches used in clinical trials with human patients [8,9]. Compounds that impact cocaine seeking behaviors during extinction training in animal models may be candidate medications for promoting inhibition of drug-seeking behaviors in human addicts.…”
Section: Resultsmentioning
confidence: 99%
“…In clinical settings, however, medications are usually not administered on an acute basis, but rather as part of a chronic (i.e., daily) treatment regimen [8,9]. It is feasible that a drug that is found to be effective after acute administration may not be as effective if delivered chronically.…”
Section: Introductionmentioning
confidence: 99%